Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD55 antibody variable domains fused with a scFv from an anti-CA9 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD55 x Anti-CA9 Bispecific Antibody (Tandem scFv) (BSFV-H295). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS